HSBC Holdings plc filings document foreign-issuer disclosures for a global banking and financial services group whose securities include ADRs. Recent Form 6-K reports cover quarterly earnings releases, investor presentations, Annual General Meeting materials, shareholder voting results, board and committee composition, and governance updates tied to the parent company.
The filing record also includes disclosures on conditional share awards under the HSBC Share Plan 2011, remuneration-related equity mechanics, base prospectus supplements for issuance programmes, and incorporation of quarterly results into registration statement materials. These documents provide formal records of HSBC's operating performance, capital-market documentation, shareholder matters, governance structure and foreign private issuer reporting.
HSBC Holdings plc is the issuer in a notice naming Sergio Tony Cardoso da Silva, identified as an heir and investor, as the person for whose account a proposed sale of HSBC ADRs is reported. Each ADR represents 5 ordinary shares. HSBC Bank plc is named in the sale details, the securities are identified as listed on the NYSE, and the acquisition nature is recorded as “Heritage.”
HSBC Holdings plc reported 17,141,942,291 issued ordinary shares of US$0.50 each as of September 29, 2026, with no shares held in treasury. The company reported the same number of total voting rights, which shareholders may use as the denominator when determining whether they must notify an interest or a change in an interest under applicable UK and Hong Kong disclosure rules.
HSBC Holdings plc issued 103,796 ordinary shares under its International Employee Share Purchase Plan from September 1 through September 29, 2026, using its existing block listing. The plan’s unallotted balance was 1,599,811 securities, compared with 1,703,607 previously. HSBC had 17,141,942,291 issued ordinary shares as of September 29, 2026; the newly issued shares rank pari passu with its existing ordinary shares.
HSBC Holdings plc concluded its buy-back announced on August 5, 2026, having repurchased for cancellation 48,657,102 ordinary shares for approximately US$998.0 million. On September 28, 2026, HSBC purchased 911,200 ordinary shares of US$0.50 each from BNP Paribas Financial Markets SNC on the Hong Kong Stock Exchange. The volume weighted average price was HK$159.5951 per share, with a high of HK$160.7000 and a low of HK$158.0000.
Across the buy-back, HSBC repurchased 31,735,502 shares on UK venues at a volume weighted average price of £15.1909 per share, and 16,921,600 shares on the Hong Kong Stock Exchange at HK$161.2887 per share.
HSBC Holdings plc reported that David Liao, Co-Chief Executive, Asia and Middle East, acquired 4,504 US$0.50 ordinary shares, and Barry O’Byrne, Chief Executive, International Wealth and Premier Banking, acquired 9 US$0.50 ordinary shares on September 25, 2026. Both acquisitions resulted from the automatic reinvestment of the second interim dividend for 2026, at a stated price of £15.19792 per share. The reported transaction values were £68,451.43 for David Liao and £136.78 for Barry O’Byrne.
HSBC Holdings plc will redeem in whole US$2,500,000,000 of its 2.251% Fixed Rate/Floating Rate Senior Unsecured Notes due 2027. The redemption price is US$1,000 per US$1,000 principal amount, plus accrued unpaid interest from and including May 22, 2026, to but excluding November 22, 2026; that interest is payable to holders of record on November 7, 2026. Subject to any conditions and/or the limited circumstances in the Twenty-Third Supplemental Indenture, the redemption price and interest payment become due on the Redemption Date. Since November 22 is not a Business Day, HSBC will pay on Monday, November 23, 2026. Interest on the securities ceases to accrue on and after the scheduled Redemption Date.
HSBC Holdings plc purchased for cancellation 871,200 ordinary shares of US$0.50 each from BNP Paribas Financial Markets SNC on September 25, 2026, as part of the buy-back announced on August 5, 2026. The highest price paid was HK$157.9000 per share, the lowest was HK$155.7000, and the volume weighted average price was HK$156.7755.
Since commencement of the buy-back, HSBC had repurchased 47,745,902 shares for approximate total consideration of US$979.4 million. Issued ordinary share capital and total voting rights were 17,141,942,291 following cancellation of shares repurchased on UK venues; there are no ordinary shares held in treasury. Cancellation of the Hong Kong purchases takes longer than cancellation of UK venue purchases, and HSBC said it will announce updated total voting rights once those shares are cancelled.
HSBC Holdings plc announced Elizabeth Alison Platt’s appointment as an Independent non-executive Director effective October 1, 2026, subject to election by shareholders at the 2027 AGM. Upon appointment, she will join the Group Remuneration, Group Risk, and Nomination and Corporate Governance committees. The Board determined that she is independent.
Subject to regulatory approval, Platt will succeed Dame Carolyn Fairbairn as Group Remuneration Committee Chair on February 24, 2027, after HSBC publishes annual results on February 23. Her director and committee-member roles carry total fees of £271,150 per annum; she will receive £150,000 per annum upon appointment as committee chair, subject to regulatory approval. Platt spent 21 years at Bupa Group and was Chief Executive Officer of Countrywide plc for four years.
HSBC Holdings plc purchased 850,800 ordinary shares of US$0.50 each from BNP Paribas Financial Markets SNC for cancellation on September 24, 2026, as part of its buy-back announced August 5, 2026. The volume weighted average price was HK$157.3554 per share, with prices ranging from HK$156.3000 to HK$158.4000. Since the buy-back began, HSBC reports 46,874,702 shares repurchased for approximately US$962.0 million in total consideration. HSBC said cancellation of the Hong Kong purchases takes longer and that it will announce updated total voting rights after those shares are cancelled.
HSBC Holdings plc granted employees 7,867,865 options on September 23, 2026, to subscribe for ordinary shares at an exercise price of GBP 12.17 per share. The grant includes 6,525,297 options with a 3-year option period and 1,342,568 with a 5-year option period.
The 3-year options are exercisable from November 1, 2029 to April 30, 2030, and the 5-year options from November 3, 2031 to April 30, 2032. The stated exercise period is no later than six months from vesting. The closing market price on the grant date was GBP 15.146. The options have no performance conditions or clawback provisions due to relevant UK tax legislation, and there are no arrangements for the company or a subsidiary to provide financial assistance to grantees.